The effect of Bifidobacterium on intestinal bacterial flora and putrefactive products in hemodialysis

Analysis of intestinal microflora revealed an imbalance in its composition characterized by overgrowth of aerobic bacteria in feces of hemodialysis patients. Balance was restored by administration of a Bifidobacterium capsule, which increased the level of Bifidobacterium. A significant decrease in the amount of putrefactive products such as fecal ammonia, phenol, and scatole was observed. No adverse effects were observed. These results indicate the usefulness of Bifidobacterium for hemodialysis patients.